Based on the success in the previous 20/20 Network, we have a host of technologies that are available for further development. These cover our various project areas, including novel contact lens cases, wettable contact lenses, posterior and anterior polymeric drug delivery systems. Many of these systems have shown safety and tolerability in animals, and some have shown efficacy in diseased animal models when paired with various therapeutics to show proof of concept. We continue to develop these technologies, improving their chemistry and optimizing their drug delivery profiles, and welcome partners who are interested in potentially utilizing these within their product pipeline. More information about these technologies can be found in the Technologies section of the website. Support for these projects may be matched up to 2:1, leveraging the C20/20 funds and other federal grants.